Evaluation of Effectiveness and Safety of Coroflex ISAR NEO Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study

What this Trial Is About

Researchers are evaluating the effectiveness and safety of Coroflex ISAR NEO stents in comparison to other drug-eluting stents for treating coronary artery stenosis and coronary artery disease in real-world clinical practice. This observational study aims to gather information on how well these stents perform and their safety profile over time. The study is led by Seung-Jung Park and involves patients undergoing percutaneous coronary intervention with the Coroflex ISAR NEO stent. Participants will receive treatment with the Coroflex ISAR NEO stent during their procedure. The study does not involve randomization or placebo groups, as it is an observational design focusing on patients treated with this specific stent device. Researchers will follow the patients after the procedure to observe outcomes and safety measures. During the study, participants will be monitored for events such as death, nonfatal myocardial infarction, and ischemic-driven target-vessel revascularization over 12 months. Additional outcomes include rates of all-cause death, cardiac death, myocardial infarction, target-lesion revascularization, stent thrombosis, stroke, and procedural success, observed over up to five years. Clinical follow-up schedules are part of the study protocol to collect these data and ensure patient safety throughout the observation period, which extends until the end of 2030.

IRIS-Coroflex NEO Cohort